Company Overview

Update
Status:
Acquired by Bristol-Myers Squibb
Founded:
2007
Headquarters:
South San Francisco, CA
Funding:
$74.2M
Categories:
Biotechnology
Description:
iPierian is a drug discovery platform developing therapies for neurodegenerative diseases such as SMA, ALS and Parkinson’s.

Detailed Description

Update

We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson's, and other major unmet medical needs.

Current Team (6)

Update

Past Team (5)

Update

Board Members and Advisors (7)

Update

Acquisitions (1)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • HQ

    951 Gateway Blvd.

    South San Francisco, CA 94080

    USA

Images (1)

Update
  • C297ee884f68e6eda1b90bffd3735f9f